In aged male Wistar rats, eight weeks of moderate-intensity resistance training combined with a multi-nutrient stack (Lactobacillus plantarum, Bifidobacterium bifidum, vitamin D, and leucine) produced synergistic upregulation of the mTORC1/IGF-1/S6K1 anabolic axis — with the combined group (ORS) significantly outperforming either intervention alone (mTORC1: ORS vs. OR, p=0.011; vs. OS, p<0.001). Crucially, the ORS group also drove Fusobacterium nucleatum to levels statistically comparable to young controls, with strong inverse correlations between Fn abundance and both S6K1 (r=−0.85) and IGF-1 (r=−0.81). The Firmicutes/Bacteroidetes ratio likewise normalized toward youthful levels only in the combined group.
The gut-muscle axis framing here is genuinely compelling. Fusobacterium nucleatum — best known as a colorectal cancer pathobiont — has emerging mechanistic links to systemic inflammation and muscle catabolism, making its suppression a plausible sarcopenia-relevant outcome. The ingredient stack mirrors interventions already studied independently in human aging: leucine activates mTORC1 directly, vitamin D modulates IGF-1 sensitivity, and specific Lactobacillus/Bifidobacterium strains measurably shift gut microbiome composition. The synergy finding — that neither diet nor exercise alone matches the combination — aligns with multi-modal geroscience frameworks gaining traction in clinical trials. However, this is a rodent study with n=7 per group, making effect-size estimates unreliable for human translation. The all-male design and absence of functional muscle-mass or strength outcomes are notable gaps. Incremental-to-confirmatory for the mechanism; the Fn-mTOR correlation is the most novel and warrants human validation.